Atorvastatin For The Reduction Of Ventricular Arrhythmias

Summary

To assess in patients with CAD \[coronary artery disease\] and an implantable defibrillator the effect of atorvastatin 80 mg versus placebo on the first recurrence of a ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation requiring ICD \[implantable cardioverter defibrillator\] intervention) within one year after randomization.

Timeline

Start

2000-02

Primary completion

—

Completion

2004-09

Drugs

Indications